|
ZNF181 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95049999485164E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06439999983488E-07 |
| Normal-vs-Stage2 |
1.64179999999625E-05 |
| Normal-vs-Stage3 |
1.340150E-02 |
| Normal-vs-Stage4 |
1.7289000000531E-06 |
| Stage1-vs-Stage2 |
8.859400E-01 |
| Stage1-vs-Stage3 |
8.861200E-01 |
| Stage1-vs-Stage4 |
1.193590E-01 |
| Stage2-vs-Stage3 |
8.280000E-01 |
| Stage2-vs-Stage4 |
3.117000E-01 |
| Stage3-vs-Stage4 |
3.509600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.72239999935076E-08 |
| Normal-vs-AfricanAmerican |
1.01750000003342E-06 |
| Normal-vs-Asian |
3.232100E-04 |
| Caucasian-vs-AfricanAmerican |
9.942400E-01 |
| Caucasian-vs-Asian |
1.477440E-01 |
| AfricanAmerican-vs-Asian |
1.969780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.65940003141685E-09 |
| Normal-vs-Female |
2.12569999999968E-05 |
| Male-vs-Female |
1.595770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.82499999998609E-06 |
| Normal-vs-Extreme_Weight |
3.26759999946802E-07 |
| Normal-vs-Obese |
3.51809999999952E-05 |
| Normal-vs-Extreme_Obese |
8.358300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.845600E-01 |
| Normal_Weight-vs-Obese |
5.954000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.401600E-01 |
| Extreme_Weight-vs-Obese |
4.738400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.315600E-01 |
| Obese-vs-Extreme_Obese |
8.482800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70139999999819E-05 |
| Normal-vs-Age(41-60Yrs) |
2.82990000000094E-06 |
| Normal-vs-Age(61-80Yrs) |
3.32770000444071E-08 |
| Normal-vs-Age(81-100Yrs) |
5.98539999999703E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.098800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.626000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.282200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.952000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.675800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.07059999941018E-08 |
| Normal-VS-Type2 PRCC |
1.06430000001989E-06 |
| Normal-VS-KIRP CIMP |
3.43349999987197E-07 |
| Normal-VS-Unclassified PRCC |
1.94384999999686E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.743600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.369500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.726200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.025210E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.518600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.094100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74801999999197E-05 |
| Normal-vs-N1 |
9.65819999976247E-07 |
| Normal-vs-N2 |
5.97609739472205E-11 |
| N0-vs-N1 |
8.588800E-01 |
| N0-vs-N2 |
3.014600E-04 |
| N1-vs-N2 |
4.08440000000398E-05 |
|
|
